Fluoxetine benefits patients of refractory monosymptomatic nocturnal enuresis
Written By : Dr. Nandita Mohan
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2022-11-28 03:30 GMT | Update On 2022-11-28 08:42 GMT
Advertisement
Nocturnal enuresis is involuntary urination that happens at night while sleeping, after the age when a person should be able to control his or her bladder. Most of us think of bedwetting as something that happens with little kids.
For children and adolescents with refractory primary monosymptomatic nocturnal enuresis (PMNE), fluoxetine therapy, a selective serotonin reuptake inhibitor, is a safe therapeutic option that produces an initial positive response. A study that appeared in the Journal of Urology found that the response rate does, however, gradually decline with time.
For more details, check out the link given below:
Fluoxetine benefits patients of refractory monosymptomatic nocturnal enuresis
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.